Pediatric GFR Calculator

Estimate glomerular filtration rate (eGFR) in children using the Bedside Schwartz equation. Determines CKD stage based on calculated eGFR to assist in evaluating pediatric kidney function.

ESTIMATED GFR
--
G5 <15G4G3bG3aG2G1 ≥90
CKD Stage
--
Kidney Function
--
k Constant Used
--
Method
--

What is Pediatric GFR?

Glomerular Filtration Rate (GFR) is the best overall measure of kidney function. It represents the volume of fluid filtered from the renal glomerular capillaries into Bowman's capsule per unit of time, typically expressed as mL/min/1.73 m² (normalized to body surface area).

In children, GFR cannot be directly measured in routine clinical practice. Instead, it is estimated using equations that incorporate serum creatinine levels and the child's height. The most widely used equation is the Bedside Schwartz formula, developed by Dr. George Schwartz and validated in the Chronic Kidney Disease in Children (CKiD) study.

Normal GFR varies with age in children. Newborns have low GFR (approximately 20–40 mL/min/1.73 m²) that gradually increases, reaching adult levels (approximately 90–120 mL/min/1.73 m²) by age 2 years. This maturation reflects the postnatal development of renal function.

Schwartz Formula

Bedside Schwartz (2009): This is the current recommended formula for estimating GFR in children aged 1–18 years when enzymatic creatinine assays are used.

eGFR = k × Height (cm) ÷ Serum Creatinine (mg/dL)
k = 0.413 (for all children with enzymatic creatinine)

Updated Schwartz (CKiD): Uses the same formula with k = 0.413 for enzymatic creatinine methods. The updated version was validated specifically in children with CKD.

Historical k values (used with Jaffe creatinine assays — now largely superseded):

Patient Groupk Value (Jaffe)k Value (Enzymatic)
Low birth weight infants (<1 year)0.33Not validated
Term infants (<1 year)0.45Not validated
Children 1–12 years0.550.413
Adolescent females 13–18 years0.550.413
Adolescent males 13–18 years0.700.413

CKD Staging in Children

StageGFR (mL/min/1.73 m²)DescriptionClinical Action
G1≥ 90Normal or highMonitor if risk factors present
G260–89Mildly decreasedAssess progression risk, manage comorbidities
G3a45–59Mild to moderately decreasedRefer to pediatric nephrologist
G3b30–44Moderately to severely decreasedActive management, prepare for complications
G415–29Severely decreasedPrepare for renal replacement therapy
G5< 15Kidney failureDialysis or transplant required

GFR and CKD Diagram

Pediatric CKD Stages by eGFR G1 ≥90 G2 60–89 G3a 45–59 G3b 30–44 G4 15–29 G5 <15 Normal Mild Mild-Mod Mod-Sev Severe Failure Monitor and manage risk factors Nephrology referral + active management Bedside Schwartz eGFR: k = 0.413 for enzymatic creatinine in all children

Creatinine Measurement Methods

The accuracy of the Schwartz equation depends critically on the creatinine assay method used:

  • Enzymatic (IDMS-traceable): This is the modern standard method calibrated to isotope dilution mass spectrometry (IDMS). The Bedside Schwartz equation with k = 0.413 was derived using enzymatic creatinine assays. This is the recommended method.
  • Jaffe (colorimetric): The older method that measures creatinine using a picric acid reaction. It is subject to interference from non-creatinine chromogens (bilirubin, glucose, certain drugs), leading to overestimation of creatinine and underestimation of GFR. The original Schwartz k values (0.55, 0.70) were developed using Jaffe assays.

Important: Using the Bedside Schwartz k value of 0.413 with a non-IDMS-calibrated Jaffe assay will significantly underestimate GFR. Always verify which creatinine assay your laboratory uses before interpreting results.

Pediatric Kidney Disease

Chronic kidney disease (CKD) in children differs from adults in etiology, presentation, and management:

  • Congenital anomalies of the kidney and urinary tract (CAKUT): The most common cause of CKD in children, accounting for approximately 50% of cases. Includes renal hypoplasia, dysplasia, and obstructive uropathy.
  • Glomerular diseases: Focal segmental glomerulosclerosis (FSGS), IgA nephropathy, lupus nephritis, and other glomerulonephritides.
  • Hereditary conditions: Polycystic kidney disease, Alport syndrome, nephronophthisis, and cystinosis.
  • Growth impact: CKD significantly affects linear growth due to metabolic acidosis, poor nutrition, renal osteodystrophy, and growth hormone resistance. Growth monitoring is essential.
  • Progression: Pediatric CKD progression is slower than in adults but has lifelong implications. Management focuses on blood pressure control, proteinuria reduction (ACE inhibitors/ARBs), nutrition optimization, and preparation for eventual renal replacement therapy.

Worked Example

An 8-year-old boy with height 120 cm and serum creatinine 0.5 mg/dL (enzymatic assay):

eGFR = 0.413 × 120 cm ÷ 0.5 mg/dL = 99.1 mL/min/1.73 m²

This corresponds to CKD Stage G1 (Normal). The child's estimated kidney function is within the normal range for age.

If the same child had a creatinine of 1.2 mg/dL:

eGFR = 0.413 × 120 ÷ 1.2 = 41.3 mL/min/1.73 m²

This corresponds to CKD Stage G3b (Moderate to Severe), warranting referral to a pediatric nephrologist for further evaluation and management.

Frequently Asked Questions

Why can't adult GFR equations be used for children?

Adult equations (CKD-EPI, MDRD) were derived from adult populations and incorporate age, sex, and race variables calibrated to adults. Children have different body composition, muscle mass relative to body size, and creatinine production rates. The Schwartz equation accounts for these differences by using height as a surrogate for muscle mass in growing children.

What is a normal GFR in children?

Normal GFR in children over age 2 is approximately 90–120 mL/min/1.73 m², similar to adults. Infants and neonates have lower GFR: approximately 20–40 mL/min/1.73 m² at birth in term infants, rising to 60–80 by 1 month and reaching adult levels by 1–2 years of age. Premature infants have even lower baseline GFR.

Can cystatin C be used instead of creatinine?

Yes. Cystatin C is an alternative biomarker for estimating GFR that is less affected by muscle mass, making it potentially more accurate in children with malnutrition, muscle wasting, or those who are very small. The CKiD study has developed combined creatinine-cystatin C equations that provide improved accuracy over creatinine alone. However, cystatin C assays are not available in all laboratories.

How often should GFR be monitored in children with CKD?

Monitoring frequency depends on CKD stage and rate of progression: G1–G2 at least annually, G3 every 3–6 months, G4–G5 every 1–3 months, or more frequently if there are acute changes. Serial measurements are more informative than single values, as they allow assessment of GFR trajectory over time.